Xingruida XDR
Ordered peptides from Xingruida XDR? Mail in a sample (US only) and let us test it.
Test my supplyXingruida XDR's purity-focus record is strongest in Retatrutide and Tirzepatide, where recent passes partly offset earlier purity misses and major fill swings. GHK-Cu, BPC-157, and Tesamorelin are more dispersed, with repeated fill or purity misses; evidence is fairly current and broad, but batch-ID gaps and Melanotan II's sparse record add uncertainty.
UK and Hong Kong filings resolve the storefront into a recent China-controlled export structure, with overdue compliance and unresolved HK directors. Infrastructure traces point to a sister peptide storefront sharing IP, nameservers and the same ASP/IIS template.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including Xingruida XDR rows.
Cancel anytime
Ordered peptides from Xingruida XDR? Mail in a sample (US only) and let us test it.
Test my supply| Date | Result | Test | Lab | Purity | Dosage | Label | COA |
|---|---|---|---|---|---|---|---|
12 Aug 2026 | Fail | Retatrutide Xingruida XDR | lab name | View COA | |||
12 Aug 2026 | Pass | Tirzepatide Xingruida XDR | lab name | View COA | |||
12 Aug 2026 | Pass | Retatrutide Xingruida XDR | lab name | View COA | |||
12 Aug 2026 | Pass | Tesamorelin Xingruida XDR | lab name | View COA | |||
12 Aug 2026 | Pass | Ipamorelin Xingruida XDR | lab name | View COA | |||
12 Aug 2026 | Pass | Tirzepatide Xingruida XDR | lab name | View COA | |||
9 Aug 2026 | Pass | Retatrutide Xingruida XDR | lab name | View COA | |||
9 Aug 2026 | Pass | TB-500 Xingruida XDR | lab name | View COA | |||
9 Aug 2026 | Pass | Tesamorelin Xingruida XDR | lab name | View COA | |||
3 Aug 2026 | Pass | Tesamorelin Xingruida XDR | lab name | View COA | |||
About Xingruida XDR test results from Finnrick
Xingruida XDR is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 9 peptides and 92 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible Xingruida XDR peptides in this dataset are BPC-157 (8 tests), GHK-Cu (9 tests) and Ipamorelin (3 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 92 recent tests.
Ordered peptides from Xingruida XDR? Mail in a sample (US only) and let us test it.
Test my supply